GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract HHSO100201100012CNOVAVAX INC

Overview

Award facts

Net obligations
$121.39M
$121,393,966of $203.20M potential value
Period of performance
Feb 24, 2011 to Feb 28, 2020
Ended
Modifications
12
Latest action Jan 8, 2025
Contract type
Definitive contract
PIID HHSO100201100012C

Description of requirement

BIOMEDICAL (ADVANCED)

Dates and value

Award date
Signed on Feb 24, 2011
Potential end of performance
Feb 27, 2020
Current value
$121,393,966Base and exercised options
Potential value (if all options are exercised)
$203,202,474

Obligations by fiscal year of action

  • FY2025: -$53,543,659 (de-obligation)
  • FY2015: $7,676,744
  • FY2014: $70,000,000
  • FY2011: $97,260,881

Total across 4 fiscal years: $121,393,966

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 8, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationROCKVILLE, MD
UEIZXHWXURNS6W8
CAGE code1UCZ4
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyNOVAVAX INC

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Office Of Assistant Secretary For Preparedness And Response
  3. OFC ASST SEC FOR PREPARENESS RES
Funded from
Public health and social services emergency fundProgram activities075-0140Federal accounts (agency financial reports)

Place of performance

Place of performance
Rockville, Montgomery County, Maryland 20850-3991
Congressional district (place of performance)
MD-06As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
4

Contract details

Subcontracting plan
Plan not requiredB
Major program
Advanced development of recombinant influenza vaccine products and manufacturing capabilities
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
Yes
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Feb 24, 2011Base obligation at award: $97,260,881
Latest action
Jan 8, 2025 — Other administrative actionModification P00012; obligation change -$53,543,659; administrative: no change in scope or value
Latest substantive action
Jun 22, 2016 — Change orderModification 10
Latest funding action
Feb 5, 2020 — Funding onlyModification P00011; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action5
  • Change order4
  • Funding only2
  • Option exercised1
13 actions recorded, Feb 24, 2011 to Jan 8, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$53,543,659
Latest action: change in base and all options
-$53,543,659

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7505
Contracting office code
75A501
Transactions recorded under this award key
13

Funding

Funding agency code
7500
Funding sub-tier code
7505
Funding office code
750501
Treasury accounts
  • 075-X-0140-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression